These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 23139383)

  • 1. Vesicular signalling and immune modulation as hedonic fingerprints: proteomic profiling in the chronic mild stress depression model.
    Bisgaard CF; Bak S; Christensen T; Jensen ON; Enghild JJ; Wiborg O
    J Psychopharmacol; 2012 Dec; 26(12):1569-83. PubMed ID: 23139383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers of anhedonic-like behavior, antidepressant drug refraction, and stress resilience in a rat model of depression.
    Christensen T; Bisgaard CF; Wiborg O
    Neuroscience; 2011 Nov; 196():66-79. PubMed ID: 21889970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic investigation of the ventral rat hippocampus links DRP-2 to escitalopram treatment resistance and SNAP to stress resilience in the chronic mild stress model of depression.
    Bisgaard CF; Jayatissa MN; Enghild JJ; Sanchéz C; Artemychyn R; Wiborg O
    J Mol Neurosci; 2007; 32(2):132-44. PubMed ID: 17873297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential proteomic analysis of the anti-depressive effects of oleamide in a rat chronic mild stress model of depression.
    Ge L; Zhu MM; Yang JY; Wang F; Zhang R; Zhang JH; Shen J; Tian HF; Wu CF
    Pharmacol Biochem Behav; 2015 Apr; 131():77-86. PubMed ID: 25641667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Escitalopram on a Rat Model of Persistent Stress-Altered Hedonic Activities: Towards a New Understanding of Stress and Depression.
    Yang SN; Wang YH; Tung CS; Ko CY; Liu YP
    Chin J Physiol; 2015 Dec; 58(6):404-11. PubMed ID: 26717919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hippocampal Over-Expression of Cyclooxygenase-2 (COX-2) Is Associated with Susceptibility to Stress-Induced Anhedonia in Mice.
    Strekalova T; Pavlov D; Trofimov A; Anthony DC; Svistunov A; Proshin A; Umriukhin A; Lyundup A; Lesch KP; Cespuglio R
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A proteomic analysis of the ventral hippocampus of rats subjected to maternal separation and escitalopram treatment.
    Marais L; Hattingh SM; Stein DJ; Daniels WM
    Metab Brain Dis; 2009 Dec; 24(4):569-86. PubMed ID: 19838779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypobaric hypoxia exposure in rats differentially alters antidepressant efficacy of the selective serotonin reuptake inhibitors fluoxetine, paroxetine, escitalopram and sertraline.
    Kanekar S; Sheth CS; Ombach HJ; Olson PR; Bogdanova OV; Petersen M; Renshaw CE; Sung YH; D'Anci KE; Renshaw PF
    Pharmacol Biochem Behav; 2018 Jul; 170():25-35. PubMed ID: 29738811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic selective serotonin reuptake inhibition modulates endothelial dysfunction and oxidative state in rat chronic mild stress model of depression.
    Matchkov VV; Kravtsova VV; Wiborg O; Aalkjaer C; Bouzinova EV
    Am J Physiol Regul Integr Comp Physiol; 2015 Oct; 309(8):R814-23. PubMed ID: 26269522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mechanisms of action of antidepressants: new data from Escitalopram].
    Fabre V; Hamon M
    Encephale; 2003; 29(3 Pt 1):259-65. PubMed ID: 12876551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Escitalopram: a selective inhibitor and allosteric modulator of the serotonin transporter].
    Mnie-Filali O; El Mansari M; Scarna H; Zimmer L; Sánchez C; Haddjeri N
    Encephale; 2007 Dec; 33(6):965-72. PubMed ID: 18789789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. R-citalopram counteracts the antidepressant-like effect of escitalopram in a rat chronic mild stress model.
    Sánchez C; Gruca P; Papp M
    Behav Pharmacol; 2003 Sep; 14(5-6):465-70. PubMed ID: 14501259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of escitalopram and ibuprofen on a depression-like phenotype induced by chronic stress in rats.
    Seo MK; Lee JG; Park SW
    Neurosci Lett; 2019 Mar; 696():168-173. PubMed ID: 30586639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluoxetine, not donepezil, reverses anhedonia, cognitive dysfunctions and hippocampal proteome changes during repeated social defeat exposure.
    Gottschalk MG; Mortas P; Haman M; Ozcan S; Biemans B; Bahn S
    Eur Neuropsychopharmacol; 2018 Jan; 28(1):195-210. PubMed ID: 29174946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 17β-Estradiol augments antidepressant efficacy of escitalopram in ovariectomized rats: Neuroprotective and serotonin reuptake transporter modulatory effects.
    Ibrahim WW; Safar MM; Khattab MM; Agha AM
    Psychoneuroendocrinology; 2016 Dec; 74():240-250. PubMed ID: 27685339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Escitalopram reversed the traumatic stress-induced depressed and anxiety-like symptoms but not the deficits of fear memory.
    Lin CC; Tung CS; Liu YP
    Psychopharmacology (Berl); 2016 Apr; 233(7):1135-46. PubMed ID: 26740318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative review of escitalopram, paroxetine, and sertraline: Are they all alike?
    Sanchez C; Reines EH; Montgomery SA
    Int Clin Psychopharmacol; 2014 Jul; 29(4):185-96. PubMed ID: 24424469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Escitalopram affects cytoskeleton and synaptic plasticity pathways in a rat gene-environment interaction model of depression as revealed by proteomics. Part II: environmental challenge.
    Piubelli C; Vighini M; Mathé AA; Domenici E; Carboni L
    Int J Neuropsychopharmacol; 2011 Jul; 14(6):834-55. PubMed ID: 21054913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of fluoxetine and adenosine receptor NECA agonist on G alpha q/11 protein of C6 glioma cells.
    Kovárů H; Kováru F; Lisá V
    Neuro Endocrinol Lett; 2012; 33(6):614-8. PubMed ID: 23160219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allosteric modulation of the effect of escitalopram, paroxetine and fluoxetine: in-vitro and in-vivo studies.
    Mansari ME; Wiborg O; Mnie-Filali O; Benturquia N; Sánchez C; Haddjeri N
    Int J Neuropsychopharmacol; 2007 Feb; 10(1):31-40. PubMed ID: 16448580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.